Corlieve Therapeutics is a France-based biotechnology company that develops and commercializes novel therapeutics for the treatment of neurological disorders.
Business Model:
Revenue: $4.9M
Employees: 11-50
Corlieve Therapeutics was acquired by
UniQure.
The acquisition happend on 2021-06-23.
Details of the transaction were not public
Address: 59 Rue de
City: Paris
State: île-de-france
Zip: 75008
Country: FR
Corlieve Therapeutics is a France-based biotechnology company that develops and commercializes novel therapeutics for the treatment of neurological disorders.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2020 | Seed | - | 11/2020 | Seed Round | 4 | - |
Idinvest Partners Kinled Holding Kurma Partners Pureos Bioventures Idinvest Partners Kinled Holding Kurma Partners Pureos Bioventures |
11/2020 | Seed | - |
Kurma Partners IDinvest Partners Pureos Bioventures Kurma Partners IDinvest Partners Pureos Bioventures |
11/2020 | Seed Round | 4 | - |
Idinvest Partners Kinled Holding Kurma Partners Pureos Bioventures Idinvest Partners Kinled Holding Kurma Partners Pureos Bioventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|